Use of chlorisondamine to assess the neurogenic contribution to blood pressure in mice: An evaluation of method
Open Access
- 15 February 2021
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 9 (3), e14753
- https://doi.org/10.14814/phy2.14753
Abstract
Chlorisondamine (CSD) has been used to assess the neurogenic contribution to blood pressure (BP) and vasomotor sympathetic tone in animal models. It is assumed that the reduction in BP following CSD administration is associated to decreases in cardiac output (CO) and peripheral resistance, reflecting cardiac and vasomotor sympathetic tone, respectively. Surprisingly, this has not been characterized experimentally in mice, despite the extensive use of this animal model in cardiovascular research. We hypothesize that a specific dose of CSD can selectively block the sympathetic vasomotor tone. To test this hypothesis, we evaluated the effects of different doses of CSD (intraperitoneal) on BP and heart rate (HR) using telemetry, and on CO using echocardiography. BP and HR in normotensive C57Bl/6J mice reduced to a similar extent by all CSD doses tested (1–6 mg/kg). CSD at 6 mg/kg also reduced CO without affecting left ventricular stroke volume or fractional shortening. On the other hand, lower doses of CSD (1 and 2 mg/kg) produced significantly larger BP and HR reductions in DOCA‐salt–induced hypertensive mice, indicating a greater neurogenic BP response. In addition, all doses of CSD reduced CO in hypertensive mice. Our data suggest that the BP response to CSD in mice likely reflects reduced CO and vasomotor sympathetic tone. We conclude that CSD can be used to assess the neurogenic contribution to BP in mice but may not be appropriate for specifically estimating vasomotor sympathetic tone.Funding Information
- National Heart, Lung, and Blood Institute (R01HL091905, R01HL122770)
- National Institute of General Medical Sciences (1P20GM130459)
This publication has 44 references indexed in Scilit:
- Brain-Targeted (Pro)renin Receptor Knockdown Attenuates Angiotensin II–Dependent HypertensionHypertension, 2012
- Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive ratsJournal of the Renin-Angiotensin-Aldosterone System, 2011
- The Ion Channel ASIC2 Is Required for Baroreceptor and Autonomic Control of the CirculationNeuron, 2009
- Cardiovascular Effects of Nicotine, Chlorisondamine, and Mecamylamine in the PigeonThe Journal of pharmacology and experimental therapeutics, 2003
- Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats.Hypertension, 1994
- Biochemical evidence of sympathetic hyperactivity in human hypertension.Hypertension, 1991
- Effects of Isoflurane on the Baroreceptor ReflexAnesthesiology, 1983
- Effect of Ganglionic Blocking Agents Upon Blood Flow and Resistance in the Superior Mesenteric Artery of the DogCirculation Research, 1956
- Studies with the Ganglionic Blocking Agent, Chlorisondamine Chloride in Unanesthetized and Anesthetized DogsCirculation Research, 1956
- A New Orally Active Quaternary Ammonium, Ganglion Blocking Drug Capable of Reducing Blood Pressure, SU-3088Circulation, 1955